CORC  > 山东大学
miR-494 inhibits cancer-initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2-positive gastric cancer
Yu, Yanxia; Yu, Xuejuan; Liu, Hong; Song, Qingxun; Yang, Yongmei
刊名INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
2018
卷号42期号:2页码:998-1007
关键词gastric cancer microRNA-494 fibroblast growth factor receptor 2 cancer-initiating cells human epidermal growth factor receptor 2-positive gastric cancer
DOI10.3892/ijmm.2018.3680
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4582133
专题山东大学
作者单位Shandong Univ, Qilu Hosp, Canc Treatment Res Ctr, 107 Wenhua West Rd, Jinan 250012, Shandong, Peop
推荐引用方式
GB/T 7714
Yu, Yanxia,Yu, Xuejuan,Liu, Hong,et al. miR-494 inhibits cancer-initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2-positive gastric cancer[J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,2018,42(2):998-1007.
APA Yu, Yanxia,Yu, Xuejuan,Liu, Hong,Song, Qingxun,&Yang, Yongmei.(2018).miR-494 inhibits cancer-initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2-positive gastric cancer.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,42(2),998-1007.
MLA Yu, Yanxia,et al."miR-494 inhibits cancer-initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2-positive gastric cancer".INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 42.2(2018):998-1007.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace